title: Deaths certified as asthma and use of medical services: a national case-control study.
abstract: BACKGROUND
  Studies have linked asthma death to either increased or decreased use of medical services.
  
  
  METHODS
  A population based case-control study of asthma deaths in 1994-8 was performed in 22 English, six Scottish, and five Welsh health authorities/boards. All 681 subjects who died were under the age of 65 years with asthma in Part I on the death certificates. After exclusions, 532 hospital controls were matched to 532 cases for age, district, and date of asthma admission/death. Data were extracted blind from primary care records.
  
  
  RESULTS
  The median age of the subjects who died was 53 years; 60% of cases and 64% of controls were female. There was little difference in outpatient attendance (55% and 55%), hospital admission for asthma (51% and 54%), and median inpatient days (20 days and 15 days) in the previous 5 years. After mutual adjustment and adjustment for sex, using conditional logistic regression, three variables were independently associated with asthma death: fewer general practice contacts (odds ratio 0.82 (95% confidence interval (CI) 0.74 to 0.91) per 5 contacts) in the previous year, more home visits (1.14 (95% CI 1.08 to 1.21) per visit) in the previous year, and fewer peak expiratory flow recordings (0.83 (95% CI 0.74 to 0.92) per occasion) in the previous 3 months. These associations were similar after adjustment for markers of severity, psychosocial factors, systemic steroids, short acting bronchodilators and antibiotics, although the association with peak flow was weakened and just lost significance.
  
  
  CONCLUSIONS
  Asthma death is associated with less use of primary care services. Both practice and patient factors may be involved and a better understanding of these may offer possibilities for reducing asthma death.
authors.affiliation: Institute of Community Health Sciences, Barts and the London, Queen Mary' School of Medicine and Dentistry, UK.
authors.forename: P M
authors.initials: PM
authors.lastname: Sturdy
authors.forename: B K
authors.initials: BK
authors.lastname: Butland
authors.forename: H R
authors.initials: HR
authors.lastname: Anderson
authors.forename: J G
authors.initials: JG
authors.lastname: Ayres
authors.forename: J M
authors.initials: JM
authors.lastname: Bland
authors.forename: B D W
authors.initials: BD
authors.lastname: Harrison
authors.forename: C
authors.initials: C
authors.lastname: Peckitt
authors.forename: C R
authors.initials: CR
authors.lastname: Victor
mesh_terms: D000280:Administration, Inhalation; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000401:mortality* / Q000628:therapy; D016022:Case-Control Studies; D005260:Female; D005541:Forced Expiratory Volume / Q000502:physiology; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data*; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D008297:Male; D008875:Middle Aged; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data; D010366:Peak Expiratory Flow Rate / Q000502:physiology; D011320:Primary Health Care / Q000706:statistics & numerical data; D013256:Steroids / Q000008:administration & dosage; D006113:United Kingdom / Q000453:epidemiology
chemical_list: D018927:Anti-Asthmatic Agents; D013256:Steroids